ProFound Therapeutics has developed tools to reveal the translatome, the full compendium of sequences translated into proteins. The company has constructed the ProFoundry Atlas, an ever-expanding database cataloging tens of thousands of novel proteins and their functionality, connectivity, and roles in health and disease. The ProFoundry Platform combines proprietary protein detection technologies, targeted high-throughput functional validation, and advanced computational tools to unearth protein factors and therapeutic targets. The Atlas and platform serve as the foundation for generating new medicines based on previously unrecognized proteins. Flagship Pioneering has initially committed $75M to advance the ProFoundry Platform and generate an initial pipeline of novel therapeutics.

Total raised

$75M

Funding rounds

1

Latest round

Equity

Latest activity

May 2022